Sagittario Milanodue, Italy

Maria Rita Gismondo

This inventor holds 1 USPTO granted patent. Top assignee: Zambon Group. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Rita Gismondo. Retrieved from https://idiyas.com/inventor/maria-rita-gismondo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Rita Gismondo: Innovator in Pharmaceutical Compositions

Introduction

Maria Rita Gismondo is a prominent inventor based in Sagittario Milanodue, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of infections caused by Chlamydia pneumoniae. Her innovative work has led to the development of valuable pharmaceutical compositions.

Latest Patents

Maria Rita Gismondo holds a patent for the "Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of Chlamydia pneumoniae infections." This patent highlights her expertise in creating effective treatments for bacterial infections.

Career Highlights

Gismondo is associated with Zambon Group S.p.a., where she continues to advance her research and development efforts. Her work has been instrumental in enhancing the pharmaceutical landscape, particularly in addressing respiratory infections.

Collaborations

Throughout her career, Maria Rita Gismondo has collaborated with notable professionals, including Giovanni Battista Colombo and Domenico Ungheri. These partnerships have fostered innovation and contributed to the success of her projects.

Conclusion

Maria Rita Gismondo's contributions to pharmaceutical innovations demonstrate her commitment to improving healthcare through effective treatments. Her work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…